Nutrien Ltd (NTR)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $33.78B
Last updated: Nov 17, 2026 at 11:06 AM ET
Nutrien Ltd (NTR) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Nutrien reported EPS of $0.49, below the $0.66 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
Analysts' consensus for the quarter ending Dec 31, 2026 is 30.3% above the $0.76 reported for the quarter ended Dec 31, 2025.
NTR's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
NTR Earnings Call
The latest NTR earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 36 quarters below that had an estimate, NTR beat 15, missed 20 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $6.06B, up 0.8% from $6.01B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.49 | $0.66 | $0.59 - $0.99 | -25.76% | Miss | -47.3% | 15 | 1 up, 9 down | Nov 4, 2026 | $6.06B |
| Jun 30, 2026 | $2.67 | $2.57 | $2.41 - $2.92 | +3.89% | Beat | +0.8% | 16 | 0 up, 9 down | Aug 5, 2026 | $10.81B |
| Mar 31, 2026 | $0.51 | $0.55 | $0.34 - $0.68 | -7.27% | Miss | +363.6% | 16 | 5 up, 4 down | May 6, 2026 | $6.05B |
| Dec 31, 2025 | $0.76 | $0.82 | $0.79 - $1.08 | -7.32% | Miss | +145.2% | 15 | 3 up, 4 down | Feb 18, 2026 | $5.34B |
| Sep 30, 2025 | $0.93 | $0.84 | $0.84 - $1.20 | +10.71% | Beat | +138.5% | 16 | 10 up, 2 down | Nov 5, 2025 | $6.01B |
| Jun 30, 2025 | $2.65 | $2.42 | $2.18 - $2.59 | +9.50% | Beat | +13.2% | 15 | 9 up, 2 down | Aug 6, 2025 | $10.44B |
| Mar 31, 2025 | $0.11 | $0.30 | $0.10 - $0.46 | -63.33% | Miss | -76.1% | 16 | 2 up, 6 down | May 7, 2025 | $5.10B |
| Dec 31, 2024 | $0.31 | $0.36 | $0.25 - $0.76 | -13.12% | Miss | -16.2% | 17 | 3 up, 6 down | Feb 19, 2025 | $5.08B |
| Sep 30, 2024 | $0.39 | $0.46 | $0.33 - $0.51 | -15.22% | Miss | +11.4% | 13 | 1 up, 1 down | Nov 6, 2024 | $5.35B |
| Jun 30, 2024 | $2.34 | $2.19 | $1.86 - $2.35 | +6.85% | Beat | -7.5% | 16 | 2 up, 0 down | Aug 7, 2024 | $10.16B |
| Mar 31, 2024 | $0.46 | $0.38 | $0.22 - $0.61 | +21.05% | Beat | -58.6% | 16 | 2 up, 0 down | May 8, 2024 | $5.39B |
| Dec 31, 2023 | $0.37 | $0.65 | $0.46 - $1.00 | -43.08% | Miss | -81.7% | 16 | 1 up, 1 down | Feb 21, 2024 | $5.66B |
| Sep 30, 2023 | $0.35 | $0.64 | $0.49 - $0.99 | -45.31% | Miss | -86.1% | 15 | 5 up, 1 down | Nov 1, 2023 | $5.63B |
| Jun 30, 2023 | $2.53 | $2.78 | $2.21 - $3.16 | -8.99% | Miss | -56.8% | 17 | 1 up, 2 down | Aug 2, 2023 | $11.65B |
| Mar 31, 2023 | $1.11 | $1.48 | $1.14 - $2.08 | -25.00% | Miss | -58.9% | 16 | 2 up, 1 down | May 10, 2023 | $6.11B |
| Dec 31, 2022 | $2.02 | $2.57 | $2.26 - $2.95 | -21.40% | Miss | -18.2% | 16 | 1 up, 1 down | Feb 15, 2023 | $7.53B |
| Sep 30, 2022 | $2.51 | $3.94 | $3.53 - $4.38 | -36.29% | Miss | +81.9% | 16 | 0 up, 3 down | Nov 2, 2022 | $8.19B |
| Jun 30, 2022 | $5.85 | $5.70 | $5.39 - $6.64 | +2.63% | Beat | +181.2% | 15 | 1 up, 2 down | Aug 3, 2022 | $14.51B |
| Mar 31, 2022 | $2.70 | $2.78 | $2.28 - $3.31 | -2.88% | Miss | +831.0% | 13 | 3 up, 1 down | May 2, 2022 | $7.66B |
| Dec 31, 2021 | $2.47 | $2.39 | $2.21 - $2.58 | +3.35% | Beat | +929.2% | 16 | 5 up, 1 down | Feb 16, 2022 | $7.27B |
| Sep 30, 2021 | $1.38 | $1.23 | $1.03 - $1.40 | +12.20% | Beat | +500.0% | 15 | N/A | Nov 1, 2021 | $6.02B |
| Jun 30, 2021 | $2.08 | $2.10 | N/A | -0.95% | Miss | +43.4% | N/A | N/A | Aug 9, 2021 | $9.76B |
| Mar 31, 2021 | $0.29 | $0.09 | N/A | +222.22% | Beat | N/A | N/A | N/A | May 3, 2021 | $4.66B |
| Dec 31, 2020 | $0.24 | $0.17 | N/A | +41.18% | Beat | +166.7% | N/A | N/A | Feb 17, 2021 | $4.10B |
| Sep 30, 2020 | $0.23 | $0.13 | N/A | +76.92% | Beat | -4.2% | N/A | N/A | Nov 2, 2020 | $4.23B |
| Jun 30, 2020 | $1.45 | $1.35 | N/A | +7.41% | Beat | -8.2% | N/A | N/A | Aug 10, 2020 | $8.43B |
| Mar 31, 2020 | -$0.12 | -$0.07 | N/A | -71.43% | Miss | -160.0% | N/A | N/A | May 6, 2020 | $4.20B |
| Dec 31, 2019 | $0.09 | $0.24 | N/A | -62.50% | Miss | -83.3% | N/A | N/A | Feb 18, 2020 | $3.54B |
| Sep 30, 2019 | $0.24 | $0.42 | N/A | -42.86% | Miss | -48.9% | N/A | N/A | Nov 4, 2019 | $4.17B |
| Jun 30, 2019 | $1.58 | $1.58 | N/A | 0.00% | In line | +6.8% | N/A | N/A | Jul 29, 2019 | $8.69B |
| Mar 31, 2019 | $0.20 | $0.25 | N/A | -20.00% | Miss | +25.0% | N/A | N/A | May 9, 2019 | $3.72B |
| Dec 31, 2018 | $0.54 | $0.53 | N/A | +1.89% | Beat | +157.1% | N/A | N/A | Feb 6, 2019 | $3.76B |
| Sep 30, 2018 | $0.47 | $0.44 | N/A | +6.82% | Beat | +487.5% | N/A | N/A | Nov 5, 2018 | $3.99B |
| Jun 30, 2018 | $1.48 | $1.40 | N/A | +5.71% | Beat | N/A | 10 | N/A | Aug 1, 2018 | $8.11B |
| Mar 31, 2018 | $0.16 | $0.23 | $0.23 - $0.33 | -30.43% | Miss | N/A | 10 | N/A | May 7, 2018 | $3.67B |
| Dec 31, 2017 | $0.21 | $0.39 | $0.18 - $0.55 | -46.15% | Miss | N/A | 6 | N/A | Jan 2, 2018 | $1.08B |
| Sep 30, 2017 | $0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 29, 2017 | $1.23B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $4.45, up 27.1% from the year before. It was $0.29 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $4.45 | +27.1% |
| Dec 31, 2024 | $3.50 | -19.7% |
| Dec 31, 2023 | $4.36 | -66.7% |
| Dec 31, 2022 | $13.08 | +110.3% |
| Dec 31, 2021 | $6.22 | +245.6% |
| Dec 31, 2020 | $1.80 | -14.7% |
| Dec 31, 2019 | $2.11 | -20.4% |
| Dec 31, 2018 | $2.65 | +813.8% |
| Dec 31, 2017 | $0.29 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,100 words across 18 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,123 | 18 | |
| 2026Q2 | Jun 30, 2026 | 8,749 | 20 | |
| 2026Q1 | Mar 31, 2026 | 7,023 | 21 | |
| 2025Q4 | Dec 31, 2025 | 7,281 | 20 | |
| 2025Q3 | Sep 30, 2025 | 6,652 | 20 | |
| 2025Q2 | Jun 30, 2025 | 6,840 | 21 | |
| 2025Q1 | Mar 31, 2025 | 8,714 | 22 | |
| 2024Q4 | Dec 31, 2024 | 7,106 | 23 |
2026Q3 Earnings Call
Opening remarks
Jeff Holzman Senior Vice President of Investor Relations and FP&A Good morning. Welcome to Nutrien's third quarter 2026 earnings call. As we conduct this call, various statements that we make about future expectations, plans, and prospects contain forward-looking information. Certain assumptions were applied in making these conclusions and forecasts. Therefore, actual results could differ materially from those contained in our forward-looking information. Additional information about these factors and assumptions is contained in our quarterly report to shareholders, as well as our most recent annual report, MD&A, and annual information form. I will now turn the call over to Ken Seitz, Nutrien's President and CEO, and Mark Thompson, our CFO, for opening comments.
Ken Seitz President and CEO Good morning. Thank you for joining us today to review our third quarter results, the outlook for our business, and the portfolio actions we have taken to enhance earnings quality and support long-term growth and free cash flow per share. Through the first nine months of 2026, Nutrien delivered structural earnings growth and increased cash returns to shareholders, supported by record potash sales volumes, strong proprietary products gross margins, and a continued focus on operational excellence. In potash, we delivered more volumes from our existing network and continued to strengthen our competitive position through mine automation, increasing the ore tons cut using automation to 53%. These investments are enhancing safety, improving productivity, and supporting our position as a low-cost and reliable supplier to global markets. In nitrogen, our North American operations continue to benefit from advantaged natural gas feedstock and a focus on reliability and debottlenecking initiatives that increase upgraded product volumes and margins. Production was consistent with our expectations, including planned turnarounds at our Lima and Redwater facilities during the third quarter. Within retail, adjusted EBITDA increased over the first nine months, supported by higher proprietary products gross margins and a strong livestock market in Australia. These benefits were partially offset by geopolitical-related market volatility that contributed to lower crop nutrient sales volumes and higher fuel costs. Across our retail business, we remain focused on helping growers improve returns through differentiated products, agronomic expertise, and efficient service. We delivered higher operating cash flows and further strengthened cash returns to shareholders. We increased share repurchases by 36% in the first nine months of 2026 and returned a total of $1.3 billion to shareholders through dividends and share repurchases. We also continued to optimize our portfolio. Since the fourth quarter of 2024, we have generated approximately $1 billion in gross proceeds from divestitures. These actions are enhancing earnings quality and free cash flow, enabling disciplined capital allocation toward opportunities that offer the strongest returns and long-term value creation. Consistent with these efforts, we completed a comprehensive review of strategic alternatives for our phosphate business.
Frequently Asked Questions About NTR
Did NTR beat earnings estimates last quarter?
No. Nutrien reported EPS of $0.49 for the quarter ended Sep 30, 2026, below the $0.66 estimate by 25.76%.
What EPS do analysts expect from NTR next quarter?
The consensus EPS estimate for Nutrien for the quarter ending Dec 31, 2026 is $0.99 from 19 analysts, with estimates from $0.80 to $1.19.
How often does NTR beat earnings estimates?
Nutrien beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -11.59%.
NTR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts